Point of Care Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Platform, By Mode Of Purchase, By End User, By Region & Competition, 2021-2031F

Description

The Global Point of Care Diagnostics Market is projected to expand from USD 49.89 Billion in 2025 to USD 84.83 Billion by 2031, registering a compound annual growth rate of 9.25%. Defined as medical testing conducted near the patient to deliver rapid results independent of central laboratory infrastructure, this market is primarily driven by the increasing global prevalence of chronic and infectious diseases that require immediate clinical decision-making to improve patient outcomes. Furthermore, the rising demand for decentralized healthcare services supports the widespread adoption of these diagnostic solutions in non-hospital environments, such as home care settings and remote clinics.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 49.89 Billion
Market Size 2031	USD 84.83 Billion
CAGR 2026-2031	9.25%
Fastest Growing Segment	Lateral Flow Assays
Largest Market	North America

However, the market confronts significant challenges due to stringent regulatory frameworks that mandate high compliance costs and prolong product commercialization. These complex approval processes establish substantial financial barriers for manufacturers attempting to introduce new technologies. For instance, MedTech Europe reported that in 2024, the average fee for Quality Management System certification under the In Vitro Diagnostic Regulation was 108,307 euros. Such elevated operational expenses can stifle innovation and hinder market expansion by restricting the participation of smaller diagnostic developers.

Market Driver

Technological advancements in microfluidics and biosensors are fundamentally transforming the Global Point of Care Diagnostics Market by facilitating laboratory-quality molecular testing directly at the patient's bedside. These innovations enable the rapid detection of complex pathogens with high sensitivity, reducing dependence on centralized infrastructure and accelerating treatment initiation. The integration of automated platforms has seen a particular surge, driven by the need for precise respiratory diagnostics deployable outside traditional hospital labs; for example, Danaher Corporation's Cepheid division reported in its 'Third Quarter 2024 Earnings Release' that respiratory product diagnostics generated $425 million in revenue, highlighting the critical role of advanced molecular technologies in maintaining market momentum.

Additionally, the rising global incidence of chronic and infectious diseases acts as a primary catalyst for market expansion, necessitating immediate clinical insights to mitigate severe health outcomes. As chronic conditions like diabetes escalate, there is a growing reliance on continuous monitoring solutions that empower patient self-management and relieve pressure on emergency facilities. Notably, Abbott's 'Abbott Reports Third-Quarter 2024 Results' press release indicated that sales in its Diabetes Care division grew by 19.1 percent on an organic basis due to the widespread adoption of continuous glucose monitoring systems. This demand for effective disease management tools is further evidenced by Roche, where Diagnostics Division sales increased by 4 percent at constant exchange rates in 2024, reflecting sustained global demand for immunodiagnostic and clinical chemistry testing.

Market Challenge

Stringent regulatory frameworks impose substantial compliance costs and delay product commercialization, presenting a formidable obstacle to the growth of the Global Point of Care Diagnostics Market. These rigorous approval processes require manufacturers to allocate extensive resources to comprehensive clinical trials and detailed technical documentation, diverting capital away from research and development. This heavy compliance burden significantly extends the time-to-market for new testing solutions, creating a bottleneck that postpones revenue generation and discourages investment in novel technologies, particularly affecting smaller developers who lack the liquidity to endure prolonged non-revenue periods.

The impact of these regulatory hurdles is evident in the reduced pace of innovation and market entry. Faced with unpredictable certification timelines, manufacturers often delay or cancel product launches in key regions, which directly stalls market expansion. According to MedTech Europe, the preference for the European Union as a primary launch geography dropped by 40% among large in vitro diagnostic manufacturers in 2024 due to these implementation challenges. This statistic demonstrates a clear contraction in the deployment of new diagnostics, confirming that excessive regulatory demands are actively restricting the availability of essential medical testing and dampening overall market growth.

Market Trends

The integration of Artificial Intelligence and Machine Learning for Automated Result Interpretation is significantly advancing the Global Point of Care Diagnostics Market by improving diagnostic accuracy and streamlining clinical workflows. These technologies are increasingly embedded in diagnostic platforms to automate the analysis of complex biological data, minimizing human error and enabling non-specialized personnel to perform sophisticated testing in decentralized settings. This technological shift is supported by regulatory momentum; as noted by MedTech Dive in October 2024, the U.S. Food and Drug Administration had authorized a cumulative total of 950 AI or machine learning-enabled medical devices by August 2024, allowing manufacturers to deploy smart tools that provide real-time clinical decision support.

Simultaneously, the rising utilization of point-of-care testing in retail clinics and pharmacies is transforming healthcare delivery by establishing accessible "test-to-treat" pathways outside of traditional hospital infrastructure. Major pharmacy chains are aggressively expanding their service portfolios, integrating primary care clinics and diagnostic hubs directly into their retail footprints to capture the demand for convenient, walk-in medical services. This strategic pivot is yielding financial growth; according to the Walgreens Boots Alliance 'Fiscal Year 2024 Earnings' report, the company's U.S. Healthcare segment generated fourth-quarter sales of $2.1 billion, a 7.1 percent increase over the prior year, underscoring consumer preference for decentralized testing locations that offer immediate results and seamless connections to treatment.

Key Market Players

EKF Diagnostics
Abbott Laboratories Inc.
Siemens Healthineers Ag
F. Hoffmann-La Roche Ltd
Quidel Corporation
Danaher Corporation
Becton, Dickinson and Company
Thermo Fisher Scientific Inc
Biomerieux S.A.
Chembio Diagnostics, Inc

Report Scope

In this report, the Global Point of Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Point of Care Diagnostics Market, By Product

Glucose Monitoring Products
Cardiometabolic Monitoring Products
Infectious Disease Testing Products
Coagulation Monitoring products
Covid-19 Test Products
Others

Point of Care Diagnostics Market, By Platform

Lateral Flow Assays
Dipsticks
Microfluidics
Molecular Diagnostics
Immunoassays

Point of Care Diagnostics Market, By Mode Of Purchase

Prescription Based Products
OTC Products

Point of Care Diagnostics Market, By End User

Hospitals & Clinics
Ambulatory Surgical Centers
Others

Point of Care Diagnostics Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Point of Care Diagnostics Market.

Available Customizations:

Global Point of Care Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Point of Care Diagnostics Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring products, Covid-19 Test Products, Others)
- 5.2.2. By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays)
- 5.2.3. By Mode Of Purchase (Prescription Based Products, OTC Products)
- 5.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2025)
5.3. Market Map

6. North America Point of Care Diagnostics Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Platform
- 6.2.3. By Mode Of Purchase
- 6.2.4. By End User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Point of Care Diagnostics Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Platform
    - 6.3.1.2.3. By Mode Of Purchase
    - 6.3.1.2.4. By End User
- 6.3.2. Canada Point of Care Diagnostics Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Platform
    - 6.3.2.2.3. By Mode Of Purchase
    - 6.3.2.2.4. By End User
- 6.3.3. Mexico Point of Care Diagnostics Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Platform
    - 6.3.3.2.3. By Mode Of Purchase
    - 6.3.3.2.4. By End User

7. Europe Point of Care Diagnostics Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Platform
- 7.2.3. By Mode Of Purchase
- 7.2.4. By End User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Point of Care Diagnostics Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Platform
    - 7.3.1.2.3. By Mode Of Purchase
    - 7.3.1.2.4. By End User
- 7.3.2. France Point of Care Diagnostics Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Platform
    - 7.3.2.2.3. By Mode Of Purchase
    - 7.3.2.2.4. By End User
- 7.3.3. United Kingdom Point of Care Diagnostics Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Platform
    - 7.3.3.2.3. By Mode Of Purchase
    - 7.3.3.2.4. By End User
- 7.3.4. Italy Point of Care Diagnostics Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Platform
    - 7.3.4.2.3. By Mode Of Purchase
    - 7.3.4.2.4. By End User
- 7.3.5. Spain Point of Care Diagnostics Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Platform
    - 7.3.5.2.3. By Mode Of Purchase
    - 7.3.5.2.4. By End User

8. Asia Pacific Point of Care Diagnostics Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Platform
- 8.2.3. By Mode Of Purchase
- 8.2.4. By End User
- 8.2.5. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Point of Care Diagnostics Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Platform
    - 8.3.1.2.3. By Mode Of Purchase
    - 8.3.1.2.4. By End User
- 8.3.2. India Point of Care Diagnostics Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Platform
    - 8.3.2.2.3. By Mode Of Purchase
    - 8.3.2.2.4. By End User
- 8.3.3. Japan Point of Care Diagnostics Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Platform
    - 8.3.3.2.3. By Mode Of Purchase
    - 8.3.3.2.4. By End User
- 8.3.4. South Korea Point of Care Diagnostics Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Platform
    - 8.3.4.2.3. By Mode Of Purchase
    - 8.3.4.2.4. By End User
- 8.3.5. Australia Point of Care Diagnostics Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Platform
    - 8.3.5.2.3. By Mode Of Purchase
    - 8.3.5.2.4. By End User

9. Middle East & Africa Point of Care Diagnostics Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Platform
- 9.2.3. By Mode Of Purchase
- 9.2.4. By End User
- 9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Point of Care Diagnostics Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Platform
    - 9.3.1.2.3. By Mode Of Purchase
    - 9.3.1.2.4. By End User
- 9.3.2. UAE Point of Care Diagnostics Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Platform
    - 9.3.2.2.3. By Mode Of Purchase
    - 9.3.2.2.4. By End User
- 9.3.3. South Africa Point of Care Diagnostics Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Platform
    - 9.3.3.2.3. By Mode Of Purchase
    - 9.3.3.2.4. By End User

10. South America Point of Care Diagnostics Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Platform
- 10.2.3. By Mode Of Purchase
- 10.2.4. By End User
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Point of Care Diagnostics Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Platform
    - 10.3.1.2.3. By Mode Of Purchase
    - 10.3.1.2.4. By End User
- 10.3.2. Colombia Point of Care Diagnostics Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Platform
    - 10.3.2.2.3. By Mode Of Purchase
    - 10.3.2.2.4. By End User
- 10.3.3. Argentina Point of Care Diagnostics Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Platform
    - 10.3.3.2.3. By Mode Of Purchase
    - 10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Point of Care Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. EKF Diagnostics
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Abbott Laboratories Inc.
15.3. Siemens Healthineers Ag
15.4. F. Hoffmann-La Roche Ltd
15.5. Quidel Corporation
15.6. Danaher Corporation
15.7. Becton, Dickinson and Company
15.8. Thermo Fisher Scientific Inc
15.9. Biomerieux S.A.
15.10. Chembio Diagnostics, Inc